BNP Paribas Financial Markets’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.63M | Sell |
72,555
-49,514
| -41% | -$1.69M | ﹤0.01% | 2603 |
|
|
2026
Q1 | $4.04M | Sell |
122,069
-97,403
| -44% | -$4.12M | ﹤0.01% | 2184 |
|
|
2025
Q4 | $10.2M | Buy |
219,472
+105,063
| +92% | +$4.4M | ﹤0.01% | 1601 |
|
|
2025
Q3 | $4M | Buy |
114,409
+104,576
| +1,064% | +$3.64M | ﹤0.01% | 2136 |
|
|
2025
Q2 | $291K | Sell |
9,833
-5,117
| -34% | -$146K | ﹤0.01% | 3617 |
|
|
2025
Q1 | $446K | Sell |
14,950
-2,068
| -12% | -$63.2K | ﹤0.01% | 3254 |
|
|
2024
Q4 | $488K | Sell |
17,018
-50,516
| -75% | -$1.67M | ﹤0.01% | 3319 |
|
|
2024
Q3 | $2.61M | Sell |
67,534
-127,992
| -65% | -$4.56M | ﹤0.01% | 1904 |
|
|
2024
Q2 | $6.3M | Sell |
195,526
-57,220
| -23% | -$1.98M | 0.01% | 1298 |
|
|
2024
Q1 | $9.81M | Buy |
252,746
+106,203
| +72% | +$3.72M | 0.01% | 1093 |
|
|
2023
Q4 | $4.51M | Buy |
146,543
+79,823
| +120% | +$2M | 0.01% | 1470 |
|
|
2023
Q3 | $1.49M | Sell |
66,720
-38,325
| -36% | -$874K | ﹤0.01% | 2063 |
|
|
2023
Q2 | $2.26M | Sell |
105,045
-41,148
| -28% | -$934K | ﹤0.01% | 1686 |
|
|
2023
Q1 | $3.51M | Buy |
146,193
+81,214
| +125% | +$2.15M | ﹤0.01% | 1471 |
|
|
2022
Q4 | $1.51M | Buy |
64,979
+4,960
| +8% | +$100K | ﹤0.01% | 1927 |
|
|
2022
Q3 | $962K | Buy |
60,019
+20,759
| +53% | +$366K | ﹤0.01% | 2514 |
|
|
2022
Q2 | $696K | Buy |
39,260
+27,061
| +222% | +$455K | ﹤0.01% | 2456 |
|
|
2022
Q1 | $248K | Sell |
12,199
-3,480
| -22% | -$65.7K | ﹤0.01% | 3049 |
|
|
2021
Q4 | $293K | Sell |
15,679
-18,402
| -54% | -$359K | ﹤0.01% | 3255 |
|
|
2021
Q3 | $673K | Buy |
34,081
+21,802
| +178% | +$471K | ﹤0.01% | 2607 |
|
|
2021
Q2 | $290K | Buy |
12,279
+5,653
| +85% | +$131K | ﹤0.01% | 2761 |
|
|
2021
Q1 | $157K | Sell |
6,626
-401
| -6% | -$9.53K | ﹤0.01% | 3150 |
|
|
2020
Q4 | $141K | Sell |
7,027
-865
| -11% | -$16.9K | ﹤0.01% | 3054 |
|
|
2020
Q3 | $164K | Buy |
7,892
+6,658
| +540% | +$120K | ﹤0.01% | 2850 |
|
|
2020
Q2 | $21.6K | Sell |
1,234
-8,761
| -88% | -$172K | ﹤0.01% | 3368 |
|
|
2020
Q1 | $163K | Buy |
9,995
+6,189
| +163% | +$128K | ﹤0.01% | 2963 |
|
|
2019
Q4 | $78.3K | Sell |
3,806
-992
| -21% | -$16.5K | ﹤0.01% | 3407 |
|
|
2019
Q3 | $55.1K | Buy |
4,798
+1,512
| +46% | +$17.3K | ﹤0.01% | 3423 |
|
|
2019
Q2 | $43.2K | Sell |
3,286
-2,830
| -46% | -$37.8K | ﹤0.01% | 3511 |
|
|
2019
Q1 | $92.6K | Buy |
6,116
+6,107
| +67,856% | +$97.8K | ﹤0.01% | 3167 |
|
|
2018
Q4 | $155 | Sell |
9
-957
| -99% | -$16.4K | ﹤0.01% | 4129 |
|
|
2018
Q3 | $14.2K | Sell |
966
-294
| -23% | -$5.21K | ﹤0.01% | 3582 |
|
|
2018
Q2 | $30.1K | Sell |
1,260
-4,051
| -76% | -$99.6K | ﹤0.01% | 3327 |
|
|
2018
Q1 | $136K | Sell |
5,311
-327
| -6% | -$7.79K | ﹤0.01% | 3032 |
|
|
2017
Q4 | $104K | Buy |
5,638
+3,561
| +171% | +$51K | ﹤0.01% | 3278 |
|
|
2017
Q3 | $21.8K | Sell |
2,077
-114
| -5% | -$1.26K | ﹤0.01% | 3551 |
|
|
2017
Q2 | $27.4K | Buy |
2,191
+2,167
| +9,029% | +$21.4K | ﹤0.01% | 3481 |
|
|
2017
Q1 | $241 | Sell |
24
-845
| -97% | -$12.6K | ﹤0.01% | 3942 |
|
|
2016
Q4 | $13.5K | Sell |
869
-46
| -5% | -$764 | ﹤0.01% | 3327 |
|
|
2016
Q3 | $17.6K | Buy |
915
+385
| +73% | +$4.57K | ﹤0.01% | 2961 |
|
|
2016
Q2 | $6.28K | Buy |
+530
| New | +$8.76K | ﹤0.01% | 3151 |
|
|
2016
Q1 | – | Sell |
-1,398
| Closed | -$38.4K | – | 2745 |
|
|
2015
Q4 | $38.4K | Buy |
1,398
+20
| +1% | +$421 | ﹤0.01% | 2986 |
|
|
2015
Q3 | $30.5K | Buy |
+1,378
| New | +$24.9K | ﹤0.01% | 3160 |
|
Other funds holding COLL
JTL
EAM
BNP Paribas Financial Markets's COLL Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Collegium Pharmaceutical (COLL) stake by 41% in Q2 2026, selling an estimated $1.69M and leaving 72,555 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2603.
BNP Paribas Financial Markets first reported a position in COLL in Q3 2015 and has held it in 43 quarters since. The position peaked at $10.2M in Q4 2025. 257 funds tracked by Wall St. Rank hold COLL as of Q2 2026.
- BNP Paribas Financial Markets held 72,555 shares of Collegium Pharmaceutical worth $2.63M as of Q2 2026.
- BNP Paribas Financial Markets sold 49,514 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.69M.
- Collegium Pharmaceutical made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2603 holding.
- BNP Paribas Financial Markets first reported a position in Collegium Pharmaceutical in Q3 2015 and has held it in 43 quarters since.
- BNP Paribas Financial Markets's Collegium Pharmaceutical position peaked at $10.2M in Q4 2025.
- 257 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.